Rankings
▼
Calendar
CGEM Q2 2023 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
Q2 2023 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$38M
Net Income
-$32M
EPS (Diluted)
$-0.81
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$522M
Total Liabilities
$22M
Stockholders' Equity
$500M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$38M
$240M
-115.7%
Net Income
-$32M
$175M
-118.4%
← FY 2023
All Quarters
Q3 2023 →